Abstract
Modern pathology is built around the principle of preserving tissues such that the in vivo molecular status is maintained at levels representative of the disease state. Tissues are immersed in a solution of fixative which slowly inactivates biological activities, thus preserving the sample. Further processing ultimately allows the tissue to be embedded into wax for thin sectioning and staining for interpretation microscopically. Every year, around 7 billion tissue samples are submitted for processing in the United States alone. With this huge workload, histology laboratories are looking for faster methods of performing fixation, which currently require from several hours to days to complete. Ideally, this procedure could be standardized and would be quicker with better preservation over a wide range of biologically relevant molecules.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fox CH, Johnson FB, Whiting J, Roller PP (1985) J Histochem Cytochem 33:845–853
Tan DS, Thomas GV, Garrett MD, Banerji U, de Bono JS, Kaye SB, Workman P (2009) Cancer J 15:406–420
Yokota T (2014) Int J Clin Oncol 19:211–219
Sierra JR, Tsao MS (2011) Ther Adv Med Oncol 3:S21–35
Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT (2013) Oncogene 33:2949–2955
Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S (2009) Mod Pathol 22:1457–1467
Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM (2009) Clin Cancer Res 15:7381–7388
Sauter G, Lee J, Bartlett JM, Slamon DJ, Press MF (2009) J Clin Oncol 27:1323–1333
Juhl H (2010) Scand J Clin Lab Invest Suppl 242:63–65
Chafin D, Theiss A, Roberts E, Borlee G, Otter M, Baird GS (2013) PLoS ONE 8:e54138
Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JMS, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) J Clin Oncol 31:3997–4014
Morales AR, Essenfeld H, Essenfeld E, Duboue MC, Vincek V, Nadji M (2002) Arch Pathol Lab Med 126:583–590
Adams D (2004) Am J Clin Pathol 122:612–613, 613–614
Ainley CD, Ironside JW (1994) J Neurosci Methods 55:183–190
Antunes L, Montagne K, Weinbreck N, Marchal L, Thiebault D, Bonnet C, Gauche D, Plenat F (2006) Histopathology 48:471–473
Alcolea MP, Casado P, Rodriguez-Prados JC, Vanhaesebroeck B, Cutillas PR (2012) Mol Cell Proteomics 11:453–466
Andersen E, Bashir H, Archer GT (1981) Vox Sang 40:44–47
Angelini S, Ravegnini G, Fletcher JA, Maffei F, Hrelia P (2013) Pharmacogenomics 14:941–956
Chen YM (2013) J Chin Med Assoc 76:249–257
Cheng L, Zhang S, Alexander R, Yao Y, MacLennan GT, Pan CX, Huang J, Wang M, Montironi R, Lopez-Beltran A (2011) Future Oncol 7:519–541
Drier Y, Sheffer M, Domany E (2013) Proc Natl Acad Sci USA 110:6388–6393
Al-Bazz YO, Underwood JC, Brown BL, Dobson PR (2009) Eur J Cancer 45:694–704
Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF 3rd, Liotta LA (2008) Mol Cell Proteomics 7:1998–2018
Szanto A, Bognar Z, Szigeti A, Szabo A, Farkas L, Gallyas F Jr (2009) Anticancer Res 29:159–164
Wolf C, Jarutat T, Vega Harring S, Haupt K, Babitzki G, Bader S, David K, Juhl H, Arbogast S (2013) Histopathology 64:431–444
Baek JM, Jin Q, Ensor J, Boulbes DR, Esteva FJ (2011) Breast Cancer Res Treat 130:1029–1036
Betts G, Valentine H, Pritchard S, Swindell R, Williams V, Morgan S, Griffiths EA, Welch I, West C, Womack C (2013) Virchows Arch 464:145–156
Bravata V, Cammarata FP, Forte GI, Minafra L (2013) OMICS 17:119–129
Buzdar AU (2009) Ann Oncol 20:993–999
Dean-Colomb W, Esteva FJ (2008) Eur J Cancer 44:2806–2812
Esteva FJ, Cheli CD, Fritsche H, Fornier M, Slamon D, Thiel RP, Luftner D, Ghani F (2005) Breast Cancer Res 7:R436–443
Esteva FJ, Guo H, Zhang S, Santa-Maria C, Stone S, Lanchbury JS, Sahin AA, Hortobagyi GN, Yu D (2010) Am J Pathol 177:1647–1656
Figueroa-Magalhaes MC, Jelovac D, Connolly RM, Wolff AC (2014) The Breast 23:e128–136
Gonzalez-Angulo AM (2011) Clin Adv Hematol Oncol 8:873–874
Fentz AK, Sporl M, Spangenberg J, List HJ, Zornig C, Dorner A, Layer P, Juhl H, David KA (2007) Proteomics Clin Appl 1:536–544
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chafin, D. (2015). Two-Temperature Formalin Fixation Preserves Activation States Efficiently. In: Dietel, M., Wittekind, C., Bussolati, G., von Winterfeld, M. (eds) Pre-Analytics of Pathological Specimens in Oncology. Recent Results in Cancer Research, vol 199. Springer, Cham. https://doi.org/10.1007/978-3-319-13957-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-13957-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13956-2
Online ISBN: 978-3-319-13957-9
eBook Packages: MedicineMedicine (R0)